glenmark science

Glenmark Pharmaceuticals rises on getting USFDA’s nod for Sodium Phenylbutyrate Tablets

by
glenmark pharmaceuticals arm receives anda approval for solifenacin succinate tablets

Glenmark Pharmaceuticals is currently trading at Rs. 418.30, up by 5.10 points or 1.23% from its previous closing of Rs. 404.40 on the BSE. The scrip opened at Rs. 412.15 and has touched a high and low of Rs. 418.00 and Rs. 412.15 respectively. So far 8167 shares were traded on the counter. The BSE … Read more

Glenmark gains on becoming first company in India to launch Teneligliptin + Dapagliflozin Fixed Dose Combination

by
glenmark pharmaceuticals arm receives anda approval for solifenacin succinate tablets

Glenmark Pharmaceuticals is currently trading at Rs. 398.00, up by 2.60 points or 0.66% from its previous closing of Rs. 395.40 on the BSE. The scrip opened at Rs. 396.60 and has touched a high and low of Rs. 403.00 and Rs. 392.65 respectively. So far 21781 shares were traded on the counter. The BSE … Read more